WINNERS & LOSERS: Vega ups Vodafone stake; GSK drug trial disappoints
(Alliance News) - The following are the leading risers and fallers among FTSE 100 and 250 index constituents on Friday. Read More
| Price | 322.60p on 17-07-2026 at 17:25:09 |
|---|---|
| Change | 8.60p 2.74% |
| Buy | 327.00p |
| Sell | 326.40p |
| Last Trade: | Sell 1.00 at 322.60p |
| Day's Volume: | 1,654,115 |
| Last Close: | 322.60p |
| Open: | 311.00p |
| ISIN: | GB00BND88V85 |
| Day's Range | 311.00p - 337.60p |
| 52wk Range: | 212.00p - 363.40p |
| Market Capitalisation: | £2.82b |
| VWAP: | 324.09393p |
| Shares in Issue: | 875.41m |
Bridgepoint (BPT) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Sell* | 1 | 322.60p | Ordinary |
16:35:37 - 17-Jul-26 |
| Sell* | 814,063 | 322.60p | Uncrossing Trade |
16:35:24 - 17-Jul-26 |
| Sell* | 1 | 326.40p | Automatic Execution |
16:29:56 - 17-Jul-26 |
| Buy* | 23 | 327.00p | Automatic Execution |
16:29:51 - 17-Jul-26 |
| Buy* | 26 | 326.80p | Automatic Execution |
16:29:51 - 17-Jul-26 |
| Sell* | 224 | 326.40p | Automatic Execution |
16:29:31 - 17-Jul-26 |
| Sell* | 517 | 326.40p | Automatic Execution |
16:29:31 - 17-Jul-26 |
| Sell* | 200 | 326.40p | Automatic Execution |
16:29:31 - 17-Jul-26 |
| Unknown* | 272 | 326.60p | SI Trade |
16:29:05 - 17-Jul-26 |
| Buy* | 326 | 326.60p | Automatic Execution |
16:29:05 - 17-Jul-26 |
Bridgepoint (BPT) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 17th Jul 2026 7:00 am | RNS | Half-year Report |
| 29th Jun 2026 7:00 am | RNS | Acquisition of Kane Anderson Real Estate |
| 9th Jun 2026 7:00 am | RNS | Holding(s) in Company |
| 12th May 2026 4:15 pm | RNS | Result of AGM |
| 1st Apr 2026 4:00 pm | RNS | Director/PDMR Shareholding |
| 1st Apr 2026 4:00 pm | RNS | Director/PDMR Shareholding |
| 1st Apr 2026 7:00 am | RNS | Total Voting Rights |
| 26th Mar 2026 10:00 am | RNS | Annual Report and Accounts and Notice of AGM |
| 23rd Mar 2026 10:45 am | RNS | Issue of Equity and Total Voting Rights |
| 16th Mar 2026 11:30 am | RNS | Director/PDMR Shareholding |